お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
408772

経カテーテル心臓弁:医療機器のパイプライン評価

Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 264 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
経カテーテル心臓弁:医療機器のパイプライン評価
出版日: 2020年10月31日
発行: GlobalData
ページ情報: 英文 264 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の経カテーテル心臓弁市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 経カテーテル心臓弁の概要

第3章 現在治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:領域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 経カテーテル心臓弁:各企業で現在治験中のパイプライン製品

  • 経カテーテル心臓弁の企業:治験段階別のパイプライン製品
  • 経カテーテル心臓弁:治験段階別のパイプライン製品

第5章 経カテーテル心臓弁の企業・製品の概要

  • Abbott Vascular Inc.
    • パイプライン製品および進行中の治験の概要
  • Admedus Ltd
  • Advanced Bio Prosthetic Surfaces Ltd.
  • Aegis Surgical Limited
  • Annulon
  • AorTech International Plc
  • Arbor Surgical Technologies, Inc.
  • Boston Scientific Corp
  • Celyad SA
  • Cephea Valve Technologies, Inc.
  • Children's Hospital Boston
  • Clemson University
  • Colibri Heart Valve, LLC
  • Direct Flow Medical Inc
  • Dura LLC
  • Edwards Lifesciences Corp
  • Emory University
  • Endoluminal Technology Research, LLC
  • Hansen Medical Inc
  • HighLife SAS
  • HLT, Inc.
  • InterVene Inc.
  • JC Medical, Inc.
  • JenaValve Technology GmbH
  • Mayo Clinic US
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • Micro Interventional Devices, Inc.
  • MicroPort Scientific Corp
  • Mitralix Ltd.
  • MitrAssist Ltd.
  • MValve Technologies Ltd.
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc
  • PolyNova Cardiovascular LLC
  • RegenaGraft
  • SAS Cormove
  • Sino Medical Sciences Technology Inc.
  • St. Jude Medical Inc
  • Symetis AG
  • Thubrikar Aortic Valve, Inc.
  • Universiteit Utrecht
  • University College London
  • University of California San Francisco
  • University of Cambridge
  • University of Iowa
  • Valtech Cardio Ltd
  • Venus MedTech
  • Xeltis AG

第6章 経カテーテル心臓弁市場:昨今の動向

第7章 付録

図表一覧

図表

List of Tables

List of Tables

  • Table 1: Transcatheter Heart Valves - Pipeline Products by Stage of Development
  • Table 2: Transcatheter Heart Valves - Pipeline Products by Segment
  • Table 3: Transcatheter Heart Valves - Pipeline Products by Territory
  • Table 4: Transcatheter H

List of Figures

List of Figures

  • Figure 1: Transcatheter Heart Valves - Pipeline Products by Stage of Development
  • Figure 2: Transcatheter Heart Valves - Pipeline Products by Segment
  • Figure 3: Transcatheter Heart Valves - Pipeline Products by Territory
  • Figure 4: Transcatheter Heart Valves - Pipeline Products by Regulatory Path
  • Figure 5: Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
  • Figure 6: Transcatheter Heart Valves - Ongoing Clinical Trials
目次
Product Code: GDME1013EPD

GlobalData's Medical Devices sector report, "Transcatheter Heart Valves - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Transcatheter Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transcatheter Heart Valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. These valves can be either balloon expandable or self-expandable.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transcatheter Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Transcatheter Heart Valves Overview

3 Products under Development

  • 3.1 Transcatheter Heart Valves - Pipeline Products by Stage of Development
  • 3.2 Transcatheter Heart Valves - Pipeline Products by Segment
  • 3.3 Transcatheter Heart Valves - Pipeline Products by Territory
  • 3.4 Transcatheter Heart Valves - Pipeline Products by Regulatory Path
  • 3.5 Transcatheter Heart Valves - Pipeline Products by Estimated Approval Date
  • 3.6 Transcatheter Heart Valves - Ongoing Clinical Trials

4 Transcatheter Heart Valves - Pipeline Products under Development by Companies

  • 4.1 Transcatheter Heart Valves Companies - Pipeline Products by Stage of Development
  • 4.2 Transcatheter Heart Valves - Pipeline Products by Stage of Development

5 Transcatheter Heart Valves Companies and Product Overview

6 Transcatheter Heart Valves- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.